Thierry Lequerré

3.1k total citations
87 papers, 1.5k citations indexed

About

Thierry Lequerré is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Thierry Lequerré has authored 87 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Rheumatology, 25 papers in Immunology and 20 papers in Hematology. Recurrent topics in Thierry Lequerré's work include Rheumatoid Arthritis Research and Therapies (45 papers), Systemic Lupus Erythematosus Research (20 papers) and Autoimmune and Inflammatory Disorders Research (17 papers). Thierry Lequerré is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (45 papers), Systemic Lupus Erythematosus Research (20 papers) and Autoimmune and Inflammatory Disorders Research (17 papers). Thierry Lequerré collaborates with scholars based in France, New Zealand and United States. Thierry Lequerré's co-authors include Olivier Vittecoq, Xavier Le Loët, O. Mejjad, Céline Derambure, Jean Sibilia, Bruno Fautrel, A Daragon, Michel De Bandt, Maryvonne Daveau and François Tron and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Hepatology.

In The Last Decade

Thierry Lequerré

74 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thierry Lequerré France 21 733 550 504 457 156 87 1.5k
Sébastien Viatte United Kingdom 19 577 0.8× 640 1.2× 250 0.5× 307 0.7× 148 0.9× 54 1.7k
Martina Biggioggero Italy 23 1.1k 1.5× 555 1.0× 362 0.7× 181 0.4× 205 1.3× 69 1.7k
Alejandro Escudero‐Contreras Spain 21 994 1.4× 581 1.1× 361 0.7× 353 0.8× 58 0.4× 122 1.6k
Dorothy McCabe United States 17 1.3k 1.8× 896 1.6× 706 1.4× 541 1.2× 173 1.1× 37 2.5k
Jerzy Świerkot Poland 22 795 1.1× 438 0.8× 320 0.6× 254 0.6× 213 1.4× 99 1.5k
Jialin Teng China 21 481 0.7× 486 0.9× 419 0.8× 367 0.8× 59 0.4× 75 1.2k
Seung Cheol Shim South Korea 24 586 0.8× 591 1.1× 159 0.3× 386 0.8× 77 0.5× 100 1.5k
Elena Massarotti United States 18 697 1.0× 532 1.0× 241 0.5× 152 0.3× 104 0.7× 31 1.3k
Mihir D. Wechalekar Australia 22 672 0.9× 358 0.7× 184 0.4× 269 0.6× 87 0.6× 60 1.4k
Hideko Nakahara Japan 10 481 0.7× 330 0.6× 286 0.6× 227 0.5× 81 0.5× 20 1.2k

Countries citing papers authored by Thierry Lequerré

Since Specialization
Citations

This map shows the geographic impact of Thierry Lequerré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Lequerré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Lequerré more than expected).

Fields of papers citing papers by Thierry Lequerré

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Lequerré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Lequerré. The network helps show where Thierry Lequerré may publish in the future.

Co-authorship network of co-authors of Thierry Lequerré

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Lequerré. A scholar is included among the top collaborators of Thierry Lequerré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Lequerré. Thierry Lequerré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Vittecoq, Olivier, et al.. (2024). On difficulties to define prognostic factors for clinical practice in rheumatoid arthritis. RMD Open. 10(3). e004472–e004472.
3.
Moltó, Anna, Sandrine Alonso, Francis Bérenbaum, et al.. (2024). Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohort. RMD Open. 10(3). e004484–e004484. 1 indexed citations
4.
Vittecoq, Olivier, et al.. (2024). Impact of the Clinical Pharmacist in Rheumatology Practice: A Systematic Review. Healthcare. 12(15). 1463–1463. 2 indexed citations
5.
Gérard, Bénédicte, et al.. (2023). POS0242 RESPONSE TO ABATACEPT IN RHEUMATOID ARTHRITIS PATIENTS REQUIRES A SPECIFIC MACROPHAGE POLARISATION. Annals of the Rheumatic Diseases. 82. 354–355. 1 indexed citations
6.
Prati, Clément, Thierry Lequerré, Benoît Le Goff, et al.. (2023). Novel insights into the anatomy and histopathology of the sacroiliac joint and correlations with imaging signs of sacroiliitis in case of axial spondyloarthritis. Frontiers in Physiology. 14. 1182902–1182902. 1 indexed citations
7.
8.
Rodrigues, François, Laurence Cuisset, Irina Giurgea, et al.. (2022). AA amyloidosis complicating cryopyrin-associated periodic syndrome: a study of 86 cases including 23 French patients and systematic review. Lara D. Veeken. 61(12). 4827–4834. 10 indexed citations
9.
Morel, Jacques, Anne Tournadre, Jérémie Sellam, et al.. (2021). Practical management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine. 88(4). 105221–105221.
10.
Tournadre, Anne, Jérémie Sellam, Jacques Morel, et al.. (2021). Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine. 88(3). 105210–105210.
12.
Lequerré, Thierry, et al.. (2016). Rheumatoid arthritis, insulin resistance, and diabetes. Joint Bone Spine. 84(4). 411–416. 105 indexed citations
13.
Benhamou, Y., et al.. (2015). Acquired hemophilia possibly induced by etanercept in a patient with rheumatoid arthritis. Joint Bone Spine. 82(3). 200–202. 10 indexed citations
14.
Hardouin, Julie, Thierry Lequerré, Olivier Boyer, et al.. (2015). Identification of 7 Proteins in Sera of RA Patients with Potential to Predict ETA/MTX Treatment Response. Theranostics. 5(11). 1214–1224. 22 indexed citations
15.
Vittecoq, Olivier, et al.. (2013). Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease. Joint Bone Spine. 80(6). 653–655. 40 indexed citations
16.
Lequerré, Thierry, Stéphanie Beutheu, Serge Jacquot, et al.. (2011). Number and phenotype of rheumatoid arthritis patients’ CD4+CD25hi regulatory T cells are not affected by adalimumab or etanercept. Lara D. Veeken. 50(10). 1814–1822. 26 indexed citations
17.
Lequerré, Thierry, Pierre Quartier, F.Z. Alaoui, et al.. (2007). Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Annals of the Rheumatic Diseases. 67(3). 302–308. 281 indexed citations
18.
Devauchelle, Valérie, Gonzague de Pinieux, Stéphane Germain, et al.. (2006). Characterization and Functional Consequences of Underexpression of Clusterin in Rheumatoid Arthritis. The Journal of Immunology. 177(9). 6471–6479. 69 indexed citations
19.
Lequerré, Thierry, et al.. (2006). A cryopyrin-associated periodic syndrome with joint destruction. Lara D. Veeken. 46(4). 709–714. 37 indexed citations
20.
Lequerré, Thierry, Cédric Coulouarn, Céline Derambure, et al.. (2003). A new tool for rheumatology: large-scale analysis of gene expression. Joint Bone Spine. 70(4). 248–256. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026